AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31651246 — intervention group
Group type: COMPARATOR
Intervention: Control group (2.5 ml of hyperbaric bupivacaine 0.5% + 0.5 ml normal saline)
Number of subjects: 105
Study 31651246 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 105
Study 27602993 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg
Number of subjects: 18
Study 27602993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 25292351 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (acute dose)
Number of subjects: 56
Study 25292351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 23649281 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment
Number of subjects: 296
Study 23649281 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-orthodontic treatment)
Number of subjects: 296
Study 21602709 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 1905
Study 21602709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1905
Study 20021921 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose amlodipine + diuretics (group A)
Number of subjects: 13542
Study 20021921 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose amlodipine + telmisartan (group T)
Number of subjects: 13542
Study 16999566 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-related problems (DRPs) identified using a hospital adaptation of Dader's method
Number of subjects: 125
Study 14511080 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychodynamic-interpersonal therapy (PIT)
Number of subjects: 0
Study 14511080 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 10669845 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension (BIS)
Number of subjects: 670
Study 10669845 — intervention group
Group type: COMPARATOR
Intervention: Conventional asthma therapy (CAT)
Number of subjects: 670
Study 9546992 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy using 192Ir cylindrical seeds (0.3 x 0.05 cm) embedded in a nylon ribbon, delivered via an indwelling coronary catheter.
Number of subjects: 0
Study 9546992 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (control group).
Number of subjects: 0
Study 8436632 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine toothpaste (active group)
Number of subjects: 297
Study 8436632 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine toothpaste with fluoride (active group)
Number of subjects: 297
Study 8436632 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chlorhexidine)
Number of subjects: 297
Study 3524441 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal rIFN-alpha A (1.5 X 10(6) IU)
Number of subjects: 587
Study 3524441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 587
Study 31639080 — intervention group
Group type: EXPERIMENTAL
Intervention: NGO-led training
Number of subjects: 777
Study 31639080 — intervention group
Group type: EXPERIMENTAL
Intervention: Call center utilization
Number of subjects: 777
Study 31639080 — intervention group
Group type: COMPARATOR
Intervention: In-shop training from pharmaceutical company representatives
Number of subjects: 777
Study 31639080 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol-only regimen provision
Number of subjects: 777
Study 29578176 — intervention group
Group type: EXPERIMENTAL
Intervention: TPVB plus GA
Number of subjects: 40
Study 27078115 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (12 weeks, 3 times a week)
Number of subjects: 24
Study 27078115 — intervention group
Group type: COMPARATOR
Intervention: Control group (no strength training)
Number of subjects: 24
Study 27078115 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (experimental group)
Number of subjects: 24
Study 27078115 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength gains (1RM test)
Number of subjects: 24
Study 24231226 — intervention group
Group type: EXPERIMENTAL
Intervention: Risky performance of mobility activities (ADL and IADL)
Number of subjects: 245
Study 24231226 — intervention group
Group type: EXPERIMENTAL
Intervention: Declining cognition
Number of subjects: 245
Study 22521910 — intervention group
Group type: EXPERIMENTAL
Intervention: Edible taste strips containing linoleic acid (75% detection rate)
Number of subjects: 0
Study 22521910 — intervention group
Group type: EXPERIMENTAL
Intervention: Edible taste strips containing stearic acid
Number of subjects: 0
Study 22521910 — intervention group
Group type: COMPARATOR
Intervention: Nasal airflow obstruction
Number of subjects: 0
Study 22521910 — intervention group
Group type: COMPARATOR
Intervention: PROP tasters vs. non-tasters
Number of subjects: 0
Study 19680137 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEIs treatment for 6 weeks
Number of subjects: 509
Study 17602982 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline blood urea nitrogen (BUN) >40 mg/dL
Number of subjects: 0
Study 17602982 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline blood urea nitrogen (BUN) quartiles
Number of subjects: 0
Study 16283864 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated personalized goals (intervention)
Number of subjects: 80
Study 16283864 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 80
Study 11895281 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing with 4 subgingival doses of minocycline microspheres over a 6-month period (RP/M)
Number of subjects: 48
Study 11895281 — intervention group
Group type: COMPARATOR
Intervention: Conventional periodontal maintenance (PM) every 3 months
Number of subjects: 48
Study 11895281 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing with 4 subgingival doses of minocycline microspheres (RP/M)
Number of subjects: 48
Study 11895281 — intervention group
Group type: COMPARATOR
Intervention: Conventional periodontal maintenance (PM)
Number of subjects: 48
Study 9464738 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique of ureter identification and bladder pillar dissection
Number of subjects: 71
Study 9464738 — intervention group
Group type: COMPARATOR
Intervention: Traditional techniques
Number of subjects: 71
Study 7781496 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treated diabetes
Number of subjects: 600
Study 7781496 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-insulin treated diabetes
Number of subjects: 600
Study 2663744 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-containing beverage (sucrose, fructose, maltodextrin, or glucose)
Number of subjects: 18
Study 2663744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 73062 — intervention group
Group type: EXPERIMENTAL
Intervention: (+)-cyanidanol-3 (2 g/day)
Number of subjects: 100
Study 73062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31839392 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide
Number of subjects: 140
Study 31839392 — intervention group
Group type: COMPARATOR
Intervention: Traditional skin preparation
Number of subjects: 140
Study 31233896 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 108
Study 31233896 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 108
Study 31233896 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 108
Study 28099183 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 58
Study 28099183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 25913685 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition labels on pre-packaged foods
Number of subjects: 0
Study 23523485 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 87
Study 23523485 — intervention group
Group type: COMPARATOR
Intervention: Posterior-Lateral Approach (PA)
Number of subjects: 87
Study 21186075 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents
Number of subjects: 1749
Study 21186075 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 1749
Study 19950734 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 100 microg x kg(‐1)
Number of subjects: 500
Study 19950734 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1 mg x kg(‐1)
Number of subjects: 500
Study 19950734 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 500
Study 19950734 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 50 microg x kg(‐1)
Number of subjects: 500
Study 19950734 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 75 microg x kg(‐1)
Number of subjects: 500
Study 16412856 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day
Number of subjects: 108
Study 15253689 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic agents
Number of subjects: 0
Study 15253689 — intervention group
Group type: COMPARATOR
Intervention: Conventional systemic treatments
Number of subjects: 0
Study 11312479 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose milrinone (0.25 microg/kg/min)
Number of subjects: 20
Study 11312479 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 20
Study 9598225 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic preperitoneal mesh herniorrhaphy
Number of subjects: 49
Study 9598225 — intervention group
Group type: COMPARATOR
Intervention: Open preperitoneal mesh herniorrhaphy
Number of subjects: 49
Study 7943830 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (0.1 mg/kg)
Number of subjects: 200
Study 7943830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 7943830 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 200
Study 7943830 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol (0.02 mg/kg)
Number of subjects: 200
Study 2979050 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% apraclonidine
Number of subjects: 63
Study 2979050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 30075919 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable vacuum-formed retainers
Number of subjects: 42
Study 30075919 — intervention group
Group type: COMPARATOR
Intervention: Fixed retainers
Number of subjects: 42
Study 30075919 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of retainers
Number of subjects: 42
Study 26626430 — intervention group
Group type: EXPERIMENTAL
Intervention: IPX066 245-mg LD capsules under fasting conditions
Number of subjects: 0
Study 26626430 — intervention group
Group type: EXPERIMENTAL
Intervention: IPX066 245-mg LD capsules (1 and 2 capsules)
Number of subjects: 0
Study 26626430 — intervention group
Group type: COMPARATOR
Intervention: IPX066 245-mg LD capsules sprinkled on applesauce
Number of subjects: 0
Study 26626430 — intervention group
Group type: COMPARATOR
Intervention: IPX066 245-mg LD capsules after a high-fat, high-calorie meal
Number of subjects: 0
Study 25805493 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic care triage process considering personal care assistance and service methodology
Number of subjects: 20
Study 25805493 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 22936628 — intervention group
Group type: EXPERIMENTAL
Intervention: One MitraClip device
Number of subjects: 233
Study 22936628 — intervention group
Group type: EXPERIMENTAL
Intervention: Two MitraClip devices
Number of subjects: 233
Study 20960003 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg scopolamine (intravenous)
Number of subjects: 15
Study 20960003 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg mecamylamine (max. 15 mg; oral)
Number of subjects: 15
Study 20960003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 19216273 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scan analysis of maxillary sinus arteries
Number of subjects: 35
Study 16084689 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal IL-6 secretion in insomniac patients
Number of subjects: 11
Study 16084689 — intervention group
Group type: EXPERIMENTAL
Intervention: Total IL-6 secretion in insomniac patients
Number of subjects: 11
Study 16084689 — intervention group
Group type: EXPERIMENTAL
Intervention: Wake Time in insomniac patients
Number of subjects: 11
Study 16084689 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 11
Study 12848792 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 J shock
Number of subjects: 107
Study 12848792 — intervention group
Group type: COMPARATOR
Intervention: 200 J shock
Number of subjects: 107
Study 10843175 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estrogen (ethinyl estradiol, conjugated estrogen, and estradiol valerate)
Number of subjects: 2
Study 10843175 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estrogen
Number of subjects: 2
Study 10843175 — intervention group
Group type: COMPARATOR
Intervention: Transdermal estrogen
Number of subjects: 2
Study 9017755 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Practice
Number of subjects: 45
Study 9017755 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 1798836 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (1.9 mg daily)
Number of subjects: 94
Study 1798836 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (18.7 mg daily)
Number of subjects: 94
Study 1798836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 6410740 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 100
Study 6410740 — intervention group
Group type: COMPARATOR
Intervention: Meglumine iothalamate
Number of subjects: 100
Study 6410740 — intervention group
Group type: COMPARATOR
Intervention: Sodium meglumine diatrizoate
Number of subjects: 100
Study 31790890 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 g α-lipoic acid (ALA) daily for 6 months
Number of subjects: 59
Study 31790890 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ALA treatment)
Number of subjects: 59
Study 30894317 — intervention group
Group type: EXPERIMENTAL
Intervention: High MI PCI (sonothrombolysis)
Number of subjects: 50
Study 30894317 — intervention group
Group type: COMPARATOR
Intervention: PCI only (control)
Number of subjects: 50
Study 28277390 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment program (the ABC empowerment program) for 4 months
Number of subjects: 78
Study 28277390 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine clinical care)
Number of subjects: 78
Study 28277390 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment program (the ABC empowerment program)
Number of subjects: 78
Study 26719946 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal crib (FPC)
Number of subjects: 39
Study 26719946 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded lingual spur (BLS)
Number of subjects: 39
Study 26719946 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 24295024 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Cognitive-Behavioral Therapy (TCBT)
Number of subjects: 128
Study 24295024 — intervention group
Group type: COMPARATOR
Intervention: Standard Cognitive-Behavioral Therapy (SCBT)
Number of subjects: 128
Study 24295024 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TCBT and SCBT
Number of subjects: 128
Study 22089316 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine + Naltrexone
Number of subjects: 88
Study 22089316 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine + Placebo
Number of subjects: 88
Study 22089316 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine + Naltrexone
Number of subjects: 88
Study 22089316 — intervention group
Group type: COMPARATOR
Intervention: Desipramine + Placebo
Number of subjects: 88
Study 21143897 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer hormonal treatment
Number of subjects: 3424
Study 17662554 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash oral-throat rinses
Number of subjects: 561
Study 17662554 — intervention group
Group type: EXPERIMENTAL
Intervention: Water oral-throat rinses
Number of subjects: 561
Study 17662554 — intervention group
Group type: COMPARATOR
Intervention: Pharyngeal swabs
Number of subjects: 561
Study 17662554 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence of pharyngeal gonorrhea
Number of subjects: 561
Study 17662554 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence of pharyngeal chlamydia
Number of subjects: 561
Study 15812256 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg od + Hydrochlorothiazide 12.5 mg
Number of subjects: 474
Study 15812256 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg od + Hydrochlorothiazide 25 mg
Number of subjects: 474
Study 15812256 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 474
Study 16629842 — intervention group
Group type: EXPERIMENTAL
Intervention: Open‐rota system
Number of subjects: 0
Study 16629842 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard scheduling)
Number of subjects: 0
Study 9892402 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent treatment with zidovudine (AZT) plus zalcitabine (ddC)
Number of subjects: 49
Study 9892402 — intervention group
Group type: COMPARATOR
Intervention: Continuous treatment with zidovudine (AZT) plus zalcitabine (ddC)
Number of subjects: 49
Study 8897035 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric isokinetic torque (CIT) testing at velocities of 30, 60, 120, and 180 degrees.s‐1
Number of subjects: 20
Study 8897035 — intervention group
Group type: EXPERIMENTAL
Intervention: Angular delay from onset of concentric activation to peak torque at 120 and 180 degrees.s‐1
Number of subjects: 20
Study 8897035 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal dorsiflexion (DF) angle and change in passive extensibility (PE) angle
Number of subjects: 20
Study 8897035 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized peak torques and mean torques
Number of subjects: 20
Study 8897035 — intervention group
Group type: EXPERIMENTAL
Intervention: Angular delay at 120 and 180 degrees.s‐1
Number of subjects: 20
Study 1676973 — intervention group
Group type: EXPERIMENTAL
Intervention: CV 205-502
Number of subjects: 45
Study 1676973 — intervention group
Group type: COMPARATOR
Intervention: Bromocriptine
Number of subjects: 45
Study 6870216 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal enviroxime, given 6 times a day
Number of subjects: 0
Study 6870216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6870216 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal enviroxime (in volunteers without symptoms at the start of medication)
Number of subjects: 0
Study 31399115 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyber Knife (CK)
Number of subjects: 27
Study 31399115 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliding Window (SW)
Number of subjects: 27
Study 31399115 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric Modulated Arc Therapy (VMAT)
Number of subjects: 27
Study 31399115 — intervention group
Group type: EXPERIMENTAL
Intervention: Helical Tomotherapy (HT)
Number of subjects: 27
Study 31399115 — intervention group
Group type: COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy (IMRT) techniques
Number of subjects: 27
Study 29496652 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemplar messages for tobacco module
Number of subjects: 1945
Study 29496652 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages with tailored priming and an exemplar for tobacco module
Number of subjects: 1945
Study 29496652 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard priming with autonomy supportive and exemplar messages for PA, eating habits, and weight
Number of subjects: 1945
Study 29496652 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy supportive messages for PA module
Number of subjects: 1945
Study 29496652 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemplar messages for PA, eating habits, and weight-related behaviors
Number of subjects: 1945
Study 29496652 — intervention group
Group type: COMPARATOR
Intervention: Different message conditions
Number of subjects: 1945
Study 25846254 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral cementation
Number of subjects: 46
Study 25846254 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraoral cementation
Number of subjects: 46
Study 24827128 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-Doc (4 × E90C600 q3w followed by 4 × docetaxel 100 q3w, n = 1008)
Number of subjects: 2011
Study 24827128 — intervention group
Group type: COMPARATOR
Intervention: FEC (6 × F500E100C500 q3w or C600M40F600 d1, 8× q4w, n = 828 or n = 175)
Number of subjects: 2011
Study 24827128 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-Doc (in HR+ disease with high-Ki-67 tumors)
Number of subjects: 2011
Study 23185762 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue Qufeng Decoction (YHQD), one dose daily, once in the morning and once in the evening for 8 weeks
Number of subjects: 85
Study 23185762 — intervention group
Group type: COMPARATOR
Intervention: Fuyang Granule (FYG), 6 g each time, three times daily for 8 weeks
Number of subjects: 85
Study 20637961 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatropin (0.033 mg/kg/d)
Number of subjects: 0
Study 20637961 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 17922167 — intervention group
Group type: EXPERIMENTAL
Intervention: General recommendation-based program of lifestyle intervention carried out by trained professionals
Number of subjects: 335
Study 17922167 — intervention group
Group type: COMPARATOR
Intervention: Standard unstructured information given by family physicians
Number of subjects: 335
Study 15675986 — intervention group
Group type: EXPERIMENTAL
Intervention: L3/4T group (4 mg hyperbaric bupivacaine, head-down tilt)
Number of subjects: 123
Study 15675986 — intervention group
Group type: COMPARATOR
Intervention: L2/3 group (4 mg hyperbaric bupivacaine, horizontal)
Number of subjects: 123